BioAge Labs (BIOA) Current Assets (2023 - 2026)

BioAge Labs has disclosed Current Assets across 4 years of filings, most recently posting $330.3 million for Q2 2026.

• In Q2 2026, Current Assets rose 9.48% year-over-year to $330.3 million; the TTM figure through Jun 2026 stood at $330.3 million (up 9.48% YoY), while the FY2025 annual figure was $286.8 million, down 19.69% from the prior year.
• Current Assets came in at $330.3 million for Q2 2026 at BioAge Labs, down from $391.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $391.9 million in Q1 2026 to a low of $25.3 million in Q4 2023.
• Average Current Assets over 4 years is $293.9 million, with a median of $324.8 million recorded in 2025.
• Year-over-year, Current Assets soared 1311.14% in 2024 and slipped 19.69% in 2025.
• Over 4 years, Current Assets stood at $25.3 million in 2023, then soared by 1311.14% to $357.1 million in 2024, then fell by 19.69% to $286.8 million in 2025, then climbed by 15.17% to $330.3 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $330.3 million in Q2 2026, $391.9 million in Q1 2026, and $286.8 million in Q4 2025.